• linkedin
  • Increase Font
  • Sharebar

    Testis Ca care deviates from guidelines in 30% of patients

    Inappropriate imaging studies most frequent departure from guidelines, study finds

     

    Inappropriate imaging noted in 44%

    Among these 177 patients, the most frequent departure from the NCCN guidelines was the use of inappropriate imaging studies in 44% of the men (eg, unnecessary positron emission tomography scan or brain or bone imaging). Overtreatment was noted in 40% of these men, and included either an unnecessary biopsy or unnecessary chemotherapy or inappropriate drug regimen. Misdiagnosis, in terms of delayed diagnosis (antibiotics for presumed infection) or misread imaging studies, occurred in 24%. Under-treatment was detected in 16%, and it was primarily due to too few cycles of chemotherapy.

    More importantly, receiving cancer care that was different from the NCCN guidelines was identified as a significant predictor of cancer relapse. As one might expect, the higher risk of relapse was driven by under-treatment (insufficient chemotherapy), which was the strongest predictor of relapse. But other factors such as race (Hispanics) and overtreatment were also associated with increased relapse rate. Co-author Scott Eggener, MD, associate professor of surgery/urologic oncology at the University of Chicago, pointed out that “typically, patients with testicular cancer are young, otherwise healthy, and have a lifetime ahead of them; compromising cure or administering unnecessarily excessive toxicity can have profound consequences.”

    Also see - Men’s health: A forgotten topic

    The development of guidelines and standardized care protocols is an enormous task, and those who volunteer their time for these endeavors must be commended. Obvious benefits from the use of these guidelines include reduced variability in care, lower cost, lower morbidity, and improved outcomes. However, while promoting guideline utilization, we must exercise caution in our approach so that every departure from the guidelines is not viewed as harmful or negligent care. Having received fewer-than-recommended chemotherapy cycles/regimen was associated with increased risk of relapse. But the retrospective nature of the report cannot inform us about the reasons for that discrepancy (eg, excessive drug toxicity).

    Further, undergoing an extra (or unnecessary) imaging study (eg, PET scan instead of a computed tomography scan) may be quite wasteful on a societal level but not necessarily directly harmful to the individual patient.

    Testicular cancer management is often promoted as a triumph of multidisciplinary cancer care through the use of standardized protocols and guidelines. This study, among the first to examine this issue in the United States, provides valuable insight into the need for further improvement in care coordination, education, and dissemination of these standardized protocols.

    More from Urology Times:

    Ureteroscopy may adversely affect erectile function

    URS and ED risk: Intriguing association

    Genetic predictors could improve PSA accuracy


    To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll